ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
BB44
|
15 |
3.4K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
15
|
3.4K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
BB44
|
15 |
3.4K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
15
|
3.4K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
BB44
|
9 |
3.0K |
0 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
9
|
3.0K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
BB44
|
32 |
10K |
0 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
32
|
10K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
BB44
|
32 |
10K |
1 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
PPM |
Re:
Ann: Change of Director's Interest Notice
|
|
BB44
|
5 |
3.7K |
0 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
5
|
3.7K
|
0
|
|
ASX - By Stock
|
QAN |
Re:
Ann: Qantas Group Market Update
|
|
BB44
|
50 |
8.0K |
3 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
50
|
8.0K
|
3
|
|
ASX - By Stock
|
QAN Algorithmic Trading |
Re:
Alan Joyce involved in altercation in Central Sydney
|
|
BB44
|
46 |
156K |
2 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
46
|
156K
|
2
|
|
ASX - By Stock
|
QAN |
Re:
Ann: Qantas Group Market Update
|
|
BB44
|
86 |
17K |
3 |
15/10/22 |
15/10/22 |
ASX - By Stock
|
86
|
17K
|
3
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
BB44
|
31 |
9.8K |
1 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
31
|
9.8K
|
1
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Phase II Preliminary Results
|
|
BB44
|
62 |
20K |
1 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
62
|
20K
|
1
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
BB44
|
31 |
9.8K |
1 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
31
|
9.8K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to present at GCFF Virtual Conference 2022
|
|
BB44
|
11 |
4.1K |
2 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
11
|
4.1K
|
2
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
BB44
|
31 |
9.8K |
6 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
31
|
9.8K
|
6
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO presentation to Broker Meets Biotech - Perth
|
|
BB44
|
86 |
29K |
1 |
21/08/18 |
21/08/18 |
ASX - By Stock
|
86
|
29K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO presentation to Broker Meets Biotech - Perth
|
|
BB44
|
86 |
29K |
0 |
21/08/18 |
21/08/18 |
ASX - By Stock
|
86
|
29K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO presentation to Broker Meets Biotech - Perth
|
|
BB44
|
86 |
29K |
0 |
21/08/18 |
21/08/18 |
ASX - By Stock
|
86
|
29K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
run coming?
|
|
BB44
|
93 |
28K |
1 |
03/06/18 |
03/06/18 |
ASX - By Stock
|
93
|
28K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
run coming?
|
|
BB44
|
93 |
28K |
0 |
03/06/18 |
03/06/18 |
ASX - By Stock
|
93
|
28K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 4E and Annual Report 2015
|
|
BB44
|
35 |
8.6K |
1 |
27/08/15 |
27/08/15 |
ASX - By Stock
|
35
|
8.6K
|
1
|
|
ASX - By Stock
|
TIS |
Re:
Ann: Change in Strategy
|
|
BB44
|
10 |
7.8K |
3 |
28/07/15 |
28/07/15 |
ASX - By Stock
|
10
|
7.8K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Approval of PBT2 Orphan Designation for Huntingtons Disease
|
|
BB44
|
38 |
13K |
2 |
01/06/15 |
01/06/15 |
ASX - By Stock
|
38
|
13K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Longs - SP and Bashers with multiple userids
|
|
BB44
|
24 |
5.8K |
6 |
28/01/15 |
28/01/15 |
ASX - By Stock
|
24
|
5.8K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Longs - SP and Bashers with multiple userids
|
|
BB44
|
24 |
5.8K |
1 |
28/01/15 |
28/01/15 |
ASX - By Stock
|
24
|
5.8K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Longs - SP and Bashers with multiple userids
|
|
BB44
|
24 |
5.8K |
0 |
28/01/15 |
28/01/15 |
ASX - By Stock
|
24
|
5.8K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Donepezil decreases hippocampus atrophy rate but does not improve cognition
|
|
BB44
|
5 |
1.6K |
4 |
20/01/15 |
20/01/15 |
ASX - By Stock
|
5
|
1.6K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Donepezil decreases hippocampus atrophy rate but does not improve cognition
|
|
BB44
|
5 |
1.6K |
3 |
19/01/15 |
19/01/15 |
ASX - By Stock
|
5
|
1.6K
|
3
|
|
ASX - By Stock
|
TIS |
Re:
41.67% up in europe?
|
|
BB44
|
5 |
2.0K |
0 |
13/11/14 |
13/11/14 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
TIS |
Re:
41.67% up in europe?
|
|
BB44
|
5 |
2.0K |
0 |
13/11/14 |
13/11/14 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
TIS |
41.67% up in europe?
|
|
BB44
|
5 |
2.0K |
0 |
13/11/14 |
13/11/14 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
TIS |
Re:
Few Months = More Than 4
|
|
BB44
|
50 |
12K |
0 |
02/07/14 |
02/07/14 |
ASX - By Stock
|
50
|
12K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Meta-analysis: ApoE, hippocampus, amyloid deposition and brain metabolism
|
|
BB44
|
11 |
5.1K |
0 |
12/06/14 |
12/06/14 |
ASX - By Stock
|
11
|
5.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Meta-analysis: ApoE, hippocampus, amyloid deposition and brain metabolism
|
|
BB44
|
11 |
5.1K |
2 |
12/06/14 |
12/06/14 |
ASX - By Stock
|
11
|
5.1K
|
2
|
|
ASX - By Stock
|
TIS |
Re:
ce mark
|
|
BB44
|
4 |
1.9K |
8 |
03/06/14 |
03/06/14 |
ASX - By Stock
|
4
|
1.9K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 3B
|
|
BB44
|
17 |
1.7K |
0 |
08/04/14 |
08/04/14 |
ASX - By Stock
|
17
|
1.7K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
taurx, serious competition?
|
|
BB44
|
20 |
3.3K |
0 |
08/04/14 |
08/04/14 |
ASX - By Stock
|
20
|
3.3K
|
0
|
|
ASX - By Stock
|
TIS |
Re:
the competition just received ce-mark!
|
|
BB44
|
7 |
2.5K |
5 |
08/04/14 |
08/04/14 |
ASX - By Stock
|
7
|
2.5K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
taurx, serious competition?
|
|
BB44
|
20 |
3.3K |
3 |
07/04/14 |
07/04/14 |
ASX - By Stock
|
20
|
3.3K
|
3
|
|
ASX - By Stock
|
ATH |
taurx, serious competition?
|
|
BB44
|
20 |
3.3K |
0 |
04/04/14 |
04/04/14 |
ASX - By Stock
|
20
|
3.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
partnership chances
|
|
BB44
|
11 |
844 |
0 |
03/04/14 |
03/04/14 |
ASX - By Stock
|
11
|
844
|
0
|
|
ASX - By Stock
|
ATH |
Re:
cognition and function
|
|
BB44
|
22 |
1.5K |
0 |
02/04/14 |
02/04/14 |
ASX - By Stock
|
22
|
1.5K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
cognition and function
|
|
BB44
|
22 |
1.5K |
4 |
02/04/14 |
02/04/14 |
ASX - By Stock
|
22
|
1.5K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
potential with huntingon's?
|
|
BB44
|
1 |
437 |
4 |
02/04/14 |
02/04/14 |
ASX - By Stock
|
1
|
437
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Prana announces preliminary results of Alzhe
|
|
BB44
|
50 |
6.4K |
10 |
31/03/14 |
31/03/14 |
ASX - By Stock
|
50
|
6.4K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
a little bit of flag waving
|
|
BB44
|
13 |
1.8K |
2 |
29/03/14 |
29/03/14 |
ASX - By Stock
|
13
|
1.8K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
a little bit of flag waving
|
|
BB44
|
13 |
1.8K |
8 |
29/03/14 |
29/03/14 |
ASX - By Stock
|
13
|
1.8K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
seeking alpha - gamble worth taking
|
|
BB44
|
14 |
1.7K |
5 |
23/03/14 |
23/03/14 |
ASX - By Stock
|
14
|
1.7K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
seeking alpha - gamble worth taking
|
|
BB44
|
14 |
1.7K |
9 |
23/03/14 |
23/03/14 |
ASX - By Stock
|
14
|
1.7K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
peroxynitrites
|
|
BB44
|
13 |
1.3K |
2 |
12/03/14 |
12/03/14 |
ASX - By Stock
|
13
|
1.3K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
peroxynitrites
|
|
BB44
|
13 |
1.3K |
0 |
12/03/14 |
12/03/14 |
ASX - By Stock
|
13
|
1.3K
|
0
|
|